drugset / Trial / NCT04716894

A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 474121 in the Blood

NCT04716894 ↗

Phase 1 Completed 14 enrolled Boehringer Ingelheim
NaSequentialOpen-labelTreatment

Summary

The main objective of this trial is to investigate the effect on the exposure of BI 474121 in plasma when given as oral single dose together with multiple oral doses of itraconazole (Test, T) as compared to when given alone as oral single dose (Reference, R).

Timeline

Start
2021-02-01
Primary completion
2021-04-01
Completion
2021-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject BI 474121 Unknown 0.5 mg Oral
Subject Itraconazole Small molecule 200 mg Oral

Indications

No indication recorded.